China News Weekly – Hong Kong’s Jacobson Pharma Raises $64 Million for M&A

Financial Service, Life Science, Technology

Gentris and Shanghai Institute Sign MOU for Biomarker Collaboration

Life Science

FDA approves Flexion’s knee pain drug, shares surge

Life Science

Beijing is Home to Gates-Backed $100 Million Global Health Institute

Life Science

Zhejiang Huahai Raises $152 Million for New Biopharma Facility

Life Science

Hong Kong’s Jacobson Pharma Raises $64 Million for M&A

Life Science

ImmunoMet, a US HanAll Spinoff, Starts Clinical Trial of Cancer Drug

Life Science

FosunPharma in $350 Million Auction to Acquire India’s SymbiotecPharma

Life Science

MicroPort/LivaNova JV’s Pacemaker Approved for China Use

Life Science

Novo Nordisk Approved to Launch New Diabetes Treatment in China

Life Science

CR Gosun In-Licenses Antibiotic from Basilea in $152 Million Deal

Life Science

Simcere to Market Four Amgen Biosimilars in China

Life Science

China News Weekly – China’s Ping An Technology aims to generate half its business from external customers

Financial Service, Life Science, Mining, Technology

What Sectors are Being Covered at the GCFF – Toronto Conference 2017?

Energy, Financial Service, Life Science, Mining, Precious Metals, Technology

Ping An Strategically Invests in Tsumura and Becomes Its Largest Shareholder

Life Science